Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials
Dapagliflozin was found to improve glycaemic control and body weight without an increase in the risk of hypoglycemia in the DEPICT studies. No notable...
Recent Posts
-
-
What Causes Sciatica | Dr. Kalyan Bommakanti
11 May 2022 -
